Psychometric properties of medication adherence instruments in cardiovascular diseases and type 2 diabetes mellitus: a systematic review and meta-analysis

Author:

Oliveira Henrique Ceretta1ORCID,Hayashi Daisuke1,Carvalho Samantha Dalbosco Lins1,Barros Rita de Cássia Lopes1,Neves Mayza Luzia dos Santos1,Andrechuk Carla Renata Silva1,Alexandre Neusa Maria Costa1,Ribeiro Paula Aver Bretanha2,Rodrigues Roberta Cunha Matheus1

Affiliation:

1. Universidade Estadual de Campinas

2. CRCHUM: Centre Hospitalier de l'Universite de Montreal Centre de Recherche

Abstract

Abstract Background Medication adherence has a major impact on reducing mortality and healthcare costs related to the treatment of cardiovascular diseases and diabetes mellitus. The task of selecting the best PROM among the many available for this kind of patient is extremely important. This study aims to critically assess, compare and synthesize the quality of the measurement properties of patient-reported outcome measures to access medication adherence among patients with cardiovascular diseases and/or type 2 diabetes mellitus. Methods This review followed the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) and the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) guidelines. The searches were performed in Web of Science, SCOPUS, PubMed, CINAHL, EMBASE, LILACS, PsycINFO, and ProQuest (gray literature). Results A total of 94 records including 24 different PROMs were included in the review. The records were published between 1986 and 2020, most of them were conducted in the United States, and in English language. The only PROM that reached the criteria of category A, e.g., that can be recommended for use and results obtained can be trusted is the ProMAS. The PROMs that shouldn’t be recommended for use (category “c”) are the MTA, LMAS-14, GMAS, MEDS, MNPS, MALMAS, ARMS-D, DOSE-Nonadherence, MGT, MARS-5, and A-14. The remaining PROMs, e.g., MMAS-8, SMAQ, DMAS-7, ARMS-12, MTA-OA, MTA-Insulin, ARMS-10, IADMAS, MAQ, MMAS-5, ARMS-7, and 5-item questionnaire were considered as having the potential to be recommended for use (category “b”). Conclusion ProMAS is the only PROM that could be considered trusted and recommended for use for patients with cardiovascular diseases and/or type 2 diabetes mellitus. However, another 12 PROMs has the potential to be recommended for use but need further studies to ensure their quality, according to COSMIN guideline for systematic reviews of PROMs. Systematic review registration PROSPERO CRD42019129109.

Publisher

Research Square Platform LLC

Reference119 articles.

1. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors;Polonsky WH;Patient Prefer Adherence,2016

2. Cardiovascular medication adherence among patients with cardiac disease: a systematic review;Al-Ganmi AH;J Adv Nurs,2016

3. World Health Organization. https://www.who.int/data/stories/leading-causes-of-death-and-disability-2000-2019-a-visual-summary (2020). Accessed 10 Jan 2022.

4. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death (2020). Accessed 10 Jan 2022.

5. The Global Goals for Sustainable Development. https://www.globalgoals.org/3-good-health-and-well-being (2015). Accessed 10 Jan 2022.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3